Reed Smith is pleased to present a virtual life sciences CLE week, covering hot litigation and regulatory topics of interest to our pharmaceutical, biotech, and medical device clients. Details on individual sessions are below.

Speakers: Shana E. Russo Rachel B. Weil Jennifer A. Eppensteiner Kathy I. Oviedo James P. Duffy IV Gautam Bhattacharyya James M. Beck Stephen J. McConnell Ricky Raven Francisco Rivero Julia A. López Lora Spencer Paul W. Pitts Sarah L. Bruno John P. Feldman Sara A. Brinkmann Michelle A. Mantine Megan Fanale Engel Jessica R. Christensen

Event Type: Webinar, CLE / CPD

Start Date/Time:
9 November 2020, 2:30 PM ET
End Date/Time:
13 November 2020, 3:00 PM ET

The ABCs of an MDL: Lessons learned through the lens of a case

Monday, November 9 | 2:30 - 4 pm ET 

With more than half of all cases pending in the federal courts now docketed in multidistrict litigations (MDLs), companies facing large-scale litigation can likely expect to find themselves before the Judicial Panel on Multidistrict Litigation (JPML) with an MDL on the horizon.  While MDLs are most common in product liability actions, they span the gamut of mass-litigation contexts, including antitrust, air disasters, employment practices, intellectual property, sales practices, and securities. Using a product liability fact pattern, this webinar will provide an introduction to JPML and MDL procedure, including the latest trends and strategic tips for managing your caseload from corporate discovery through trial pool selection. Because many MDL cases are eventually remanded to their transferor courts, we will also discuss strategies that anticipate remand, what happens after remand, and best practices to position your clients for success at trial.

Presenters: Shana Russo, Rachel Weil, Jennifer Eppensteiner, and Kathy Oviedo

The benefits of arbitration for life sciences and health care industry disputes

Tuesday, November 10 | 10:30 - 11:30 am ET

This webinar will discuss the benefits that arbitration offers for both domestic and cross-border life sciences and health care industry disputes, including arbitrator expertise, confidentiality, procedural flexibility, more targeted documentary disclosure, global enforceability of awards, single venue proceedings, and a less combative environment that permits parties to continue doing business together. The webinar will also consider which arbitration jurisdictions and rules can be the most effective when dealing with cross-border transactions.

Presenters: Gautam Bhattacharyya and J.P. Duffy